Evidence map›Paper›PMID 28067889›Full record

Trial reportBone marrow transplantation2017

BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.

C Fair, R Shanley, J Rogosheske, A Lazaryan, B McClune, C G Brunstein, V Bachanova

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

C FairBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
R ShanleyBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
J RogosheskeBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
A LazaryanBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
B McCluneBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
C G BrunsteinBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
V BachanovaBlood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
University of Minnesota Medical Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HEATHER Hammond NELSON · 1998 to 2026
$100.4M
Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI J SUNIL RAO · 1995 to 2026
$48.2M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
NCATS NIH HHS UL1 TR000114NCI NIH HHS P01 CA065493NCI NIH HHS P30 CA077598
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationObesityTransplantation ConditioningAdultAgedAllograftsAntineoplastic Combined Chemotherapy ProtocolsCarmustineCytarabineFemaleHumansLymphomaMaleMelphalanMiddle AgedPodophyllotoxinCarmustineCytarabineMelphalanPodophyllotoxin

Identifiers

PMID28067889
PMCPMC5332312
OpenAlexW2567940562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.